Practice Areas - Equity Capital Markets Law Firms and Lawyers
| Deal Date: | 12-06-2014 | Practice Area: | Equity Capital Markets |
| Deal Title: | Lijun International Pharmaceutical Secondary Placing | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Slaughter and May, Hong Kong, advised the placing agent, a major international investment bank, in relation to the HKD2.12 billion (USD272 million) secondary placing and sale of shares in Lijun International Pharmaceutical (Holding) Co., Ltd. (Lijun), held by Prime United Industries Limited. The placing and sale of shares represents 26.28% of the issued share capital of Lijun and was undertaken by way of an accelerated bookbuilding process to institutional investors, and a sale to the chief executive officer of Lijun and Sichuan Kelun Pharmaceutical Co., Ltd., a third party corporate investor.
Lijun is a leading pharmaceutical manufacturer in the PRC and is listed on the Main Board of The Stock Exchange of Hong Kong Limited.
Corporate and Commercial: Benita Yu (partner), John Moore (partner), William Ho (associate), Norman Ho (associate).
|
||
| Financial Center: | Hong Kong | Value: | 100.01-500.00 |
| Advised Party: | Lead Manager | Law Firm | Slaughter and May |
| Issuer Jurisdiction - | Hong Kong | Listing Jurisdiction - | Hong Kong |
| Classification: |
Secondary Offerings and Placings Hong Kong Stock Exchange: |
Lawyer | Benita Yu |
